Fund HoldingsEuclidean Capital LLC

Total Portfolio Value
$439.84M
Total Bought
$9.04M
Total Sold
$0
Net Transaction
+$9.04M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
VANGUARD INTL EQUITY INDEX F3,243,4843,243,4840243,586271,64261.76%+28,056
VANGUARD INDEX FDS520,000520,0000102,024113,32425.76%+11,300
TEAMSHARES INC01,099,974+1,099,97409,0422.06%+9,042
ISHARES TR
MSCI INDIA ETF
369,600369,600017,31218,2554.15%+942
PMV PHARMACEUTICALS INC(PMVP)2,627,6432,627,64303,2583,5210.80%+263
FOGHORN THERAPEUTICS INC(FHTX)1,573,7611,573,76107,5237,6801.75%+157
TENAYA THERAPEUTICS INC(TNYA)1,015,7051,015,70507037510.17%+47
SURROZEN INC(SRZN)170,833170,8330330.00%0
ALECTOR INC1,307,8581,307,85802,8122,6290.60%-183
SURROZEN INC(SRZN)87,69687,69602,5552,2760.52%-279
ORIC PHARMACEUTICALS INC(ORIC)989,410989,410012,53610,7152.44%-1,821
Page 1 of 1
Euclidean Capital LLC — 13F Holdings — Q2 2026 | TickerTrail